What Laseroptek does

Laseroptek (legal entity: LASEROPTEK LLC) is a privately held South Korean medical device company founded in 2000 and headquartered in Seongnam-si, Gyeonggi-do, with a workforce of 51–100. The company designs, develops, and manufactures solid-state laser systems for two end markets: aesthetic dermatology (tattoo removal, pigmented lesion treatment, scar revision, skin rejuvenation, and laser toning) and medical dermatology (UV phototherapy of inflammatory skin conditions such as psoriasis, vitiligo, atopic dermatitis, and leukoderma). Its product portfolio spans picosecond titanium:sapphire lasers (HELIOS 785 PICO), picosecond Nd:YAG systems (PicoLO, PicoLO PREMIUM), Q-switched Nd:YAG systems (HELIOS III), long-pulsed Nd:YAG systems (HYPERION), Er:YAG ablative fractional lasers (LOTUS III), and 311/308nm narrowband UV lasers (PALLAS, PALLAS PREMIUM), underpinned by proprietary technologies including DOE (Diffractive Optical Element) fractional beam delivery, harmonic generation for 311nm UV output, Thermal Lens Compensation, the Dia FX fractional handpiece, and RTP (Real Twin Pulse) mode.

The business model is a B2B medical device hardware-sale model: Laseroptek sells capital equipment directly to dermatologists, aesthetic clinics, and medical institutions globally, complemented by a Partner Zone for registered distributors and resellers. Distribution is organized through dedicated regional sites for the US and Japan, and commercial outreach occurs via industry conferences (AAD, IMCAS, Korea Derma), webinars, and digital channels. The company holds multiple granted patents (PicoLO, Harmonic Generation, thermal compensation) and trademarks (DIA TONING, DIA FX), and key products carry FDA 510(k), CE, and KFDA regulatory clearances. The company is founder-led (Dr. Chu, Chairman) with no disclosed institutional ownership beyond a 2020 funding round of approximately $8.5M from HB Investment and WONIK Investment Partners, and it is currently involved in US litigation with STRATA Skin Sciences that has resulted in court-imposed restrictions on its US sales and advertising activities.

Name

Laseroptek

Legal name

LASEROPTEK LLC

Website

https://laseroptek.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

51–100 employees

Short description

Laseroptek is a South Korean medical device company (founded 2000, 51–100 employees) that designs and manufactures solid-state laser systems — including picosecond, Q-switched, Er:YAG, and narrowband UV platforms — for aesthetic and medical dermatology clinics worldwide.

Ownership category

akta.pro rank

Product category

Medical Aesthetic Laser Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845), Optical Instruments & Lenses (3827)

akta.pro primary industry

Laser & Energy-Based Dermatology (HLAKACAF)

akta.pro secondary industry

Psoriasis & Eczema Specialty Care (HLAKACAL)

Keywords

• Aesthetic laser systems
• Medical dermatology lasers
• Picosecond laser devices
• Nd:YAG laser equipment
• UV phototherapy lasers

Headquarters

HQ city

Seocho

HQ country

South Korea

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

1. Medical/Aesthetic Laser Device Sales: Sale of solid-state laser systems for dermatology and aesthetic applications. Revenue generated from direct sales of laser devices to clinics, hospitals, and medical practices.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Laseroptek develops and manufactures solid-state laser systems for dermatology and aesthetic medicine, including picosecond titanium:sapphire lasers (HELIOS 785 PICO), picosecond Nd:YAG lasers (PicoLO, PicoLO PREMIUM), Q-switched Nd:YAG lasers (HELIOS III), long-pulsed Nd:YAG systems (HYPERION), Er:YAG fractional lasers (LOTUS III), and narrowband UV 311/308nm lasers (PALLAS, PALLAS PREMIUM). The company sells these medical devices directly to dermatologists, aesthetic clinics, hospitals, and medical practices globally, complemented by a partner zone for registered distributors.

Product overview

LASEROPTEK offers a comprehensive portfolio of aesthetic and medical laser systems. The aesthetic line includes picosecond lasers (HELIOS 785 PICO, PicoLO PREMIUM, PicoLO), Q-switched Nd:YAG lasers (HELIOS III), Er:YAG ablative lasers (LOTUS III), and long-pulsed Nd:YAG systems (HYPERION). The medical line features UV laser systems (PALLAS PREMIUM, PALLAS) for inflammatory skin conditions. Key enabling technologies include proprietary DOE Fractional Technology and Ti:Sapphire laser platforms. Products are distributed under trademarks including DIA TONING® and DIA FX®.

Differentiator

Problem solved

Functional benefit

Brands

• HELIOS: Product line featuring Q-switched Nd:YAG lasers including HELIOS III (dual-wavelength 1064/532nm) and HELIOS 785 PICO (picosecond titanium:sapphire laser for melasma)
• PicoLO
• PALLAS
• LOTUS III
• HYPERION
• SCULPIO
• VASCURA589
• DIA TONING
• DIA FX

Products and services

• HELIOS 785 PICO Picosecond titanium:sapphire laser at 785nm wavelength FDA 510(k)-cleared for melasma treatment, designed for dermatologists and aesthetic clinics.
• PicoLO PREMIUM Next-generation picosecond laser with 1064/532nm dual wavelengths and upgraded Dia FX handpieces for skin rejuvenation, scars, benign pigmented lesions, and tattoo removal; targeted at dermatologists and aesthetic clinics.
• PicoLO Picosecond laser with 1064nm and 532nm wavelengths (450ps and 350ps pulse widths) with Dia FX handpiece for tattoo removal, scar correction, and skin rejuvenation; for dermatologists and aesthetic clinics.
• HELIOS III Dual-wavelength (1064/532nm) Q-switched Nd:YAG laser with stable output, consistent pulse width, and uniform beam quality for tattoo removal, pigmented lesions, and anti-aging treatments; for dermatologists and aesthetic clinics.
• LOTUS III Korea's first domestically developed fractional multi-pulse 2940nm Er:YAG laser offering modes from Ultra Short Pulse to Ultra Long Pulse for precise ablative treatments and rapid healing, with DOE Fractional Technology; for dermatologists and aesthetic clinics.
• HYPERION Long-pulsed Nd:YAG laser at 1064nm delivering up to 80J maximum energy with extended pulse capabilities and unique Flat Top beam profile for uniform emission; eligible for insurance reimbursement for onychomycosis treatment; for podiatry and aesthetic clinics.
• PALLAS PREMIUM Next-generation solid-state 311/308nm narrowband UVB laser for inflammatory skin conditions (psoriasis, vitiligo, atopic dermatitis, leukoderma), 5x faster than first-generation PALLAS, with proprietary harmonic generation technology; for medical dermatology practices.
• PALLAS World-first solid-state 311/308nm narrowband UV laser system using proprietary harmonic generation technology to treat inflammatory skin conditions including psoriasis, vitiligo, atopic dermatitis, and leukoderma; FDA, CE, and KFDA/K-ISMS cleared; for medical dermatology practices.

Quantifiable outcome

• 5 times faster treatment speed compared to PALLAS 1st generation model
• +3 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• STRATA Skin SciencesminorOthersLegal adversary relationship involving patent litigation. STRATA Skin Sciences reported court rulings restricting Laseroptek's false advertising and sales activities in the United States. This represents a competitive legal dispute rather than a commercial partnership.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Lumenis: Israel-headquartered global leader in energy-based aesthetic devices (M22, PiQo4, UltraPulse) owned by Boston Scientific. Competes across multiple Laseroptek product categories but as a much larger diversified portfolio player.
• Candela (Syneron-Candela): Global aesthetic device company (GentleLase, PicoWay, VBeam) backed by funds affiliated with Apax Partners. Competes directly in picosecond (PicoWay) and Nd:YAG segments with broader portfolio and larger salesforce.
• Solta Medical (Bausch + Lomb): Owner of Thermage, Fraxel, Clear+Brilliant, and other aesthetic energy-based devices within Bausch + Lomb's broader portfolio. Overlaps with Laseroptek in skin rejuvenation and fractional laser categories but serves a wider aesthetic device ecosystem.

Direct peers

• Cynosure: US-based aesthetic laser manufacturer offering picosecond (PicoSure), Q-switched, and ablative laser systems to dermatology and plastic surgery practices. Directly competes with Laseroptek in the picosecond tattoo-removal and pigmentation segments globally.
• Cutera: US aesthetic device company offering enlighten (picosecond), excel V, and other laser/IPL platforms to dermatologists and medical spas. Directly competes in the picosecond pigment and tattoo-removal space with a comparable clinic sales motion.
• Fotona: Slovenia-based manufacturer of Er:YAG and Nd:YAG laser systems (StarWalker, SP Dynamis) for aesthetic and dermatological applications. Comparable product mix (long-pulsed Nd:YAG, Er:YAG, picosecond-class systems) and global clinic-focused GTM.
• Quanta System: Italian manufacturer of solid-state, Q-switched, picosecond (Discovery Pico), and surgical lasers for dermatology and aesthetic medicine. Closely comparable in wavelength coverage, solid-state architecture, and clinic-focused distribution.
• Alma Lasers: Israel-based manufacturer of aesthetic and medical lasers (Soprano, Harmony, Accent, PicoClear) serving dermatology and aesthetic clinics worldwide. Directly comparable to Laseroptek across picosecond, Nd:YAG, and Er:YAG product categories with similar clinic-based GTM.
• STRATA Skin Sciences: US dermatology device company with XTRAC excimer laser and VTRAC systems for psoriasis/vitiligo. Direct competitor in the medical dermatology laser segment and Laseroptek's named litigation adversary in US courts.

Regional players

• Jeisys Medical: Korean competitor offering Potenza (RF microneedle), Legend Pro+, and other aesthetic devices with strong APAC presence and growing US footprint. Closest Korean peer, comparable in size and regional sales channels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@laseroptekkorea8106?si=JvX5rw_poSLC4zQp
• Facebookfacebook.com/laseroptekco
• LinkedInlinkedin.com/in/laseroptek
• Instagraminstagram.com/laseroptek_korea
• Xx.com/laseroptekco

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laseroptek